allogene.com

Allogene Therapeutics

Allogene Therapeutics's email is info@allogene.com .

Allogene Therapeutics is a clinical stage immuno-oncology company. It is mainly engaged in the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The company is involved in developing a pipeline of multiple allogeneic T cell product candidates utilizing validated gene editing and advanced proprietary cell manufacturing technologies. Its pipeline includes UCART19 which is developed for the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL), as well as several preclinical allogeneic CAR T therapies.
View Top Employees for Allogene Therapeutics
img Website allogene.com
img Industry Biotechnology
img Location South San Francisco, California, United States
img Employees 251
img Founded 2018
img HQ 270 Littlefield Avenue,
img Email info@allogene.com
img Funding 531,770,409 USD
img Competitors Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences,
img Website allogene.com
img Industry Biotechnology
img Location South San Francisco, California, United States
img Employees 251
img Founded 2018
img LinkedIn linkedin.com/company/allogene-therapeutics
img HQ 270 Littlefield Avenue,
img Email info@allogene.com
img Funding 531,770,409 USD

Top Allogene Therapeutics Employees